The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Journal of Clinical Medicine · 09.01.2025 · 14 (2) · 386
DOI: 10.3390/jcm14020386 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.01.2025. Verfasst von Sehwan Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Biotechnology, Kyungpook National University, Daegu 41566, Republic of Korea. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 553 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
The blood–brain barrier (BBB) is a crucial structure that maintains brain homeostasis by regulating the entry of molecules and cells from the bloodstream into the central nervous system (CNS). Neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, as well as ischemic stroke, compromise the integrity of the BBB. This leads to increased permeability and the infiltration of harmful substances, thereby accelerating neurodegeneration. In this review, we explore the mechanisms underlying BBB disruption, including oxidative stress, neuroinflammation, vascular dysfunction, and the loss of tight junction integrity, in patients with neurodegenerative diseases. We discuss how BBB breakdown contributes to neuroinflammation, neurotoxicity, and the abnormal accumulation of pathological proteins, all of which exacerbate neuronal damage and facilitate disease progression. Furthermore, we discuss potential therapeutic strategies aimed at preserving or restoring BBB function, such as anti-inflammatory treatments, antioxidant therapies, and approaches to enhance tight junction integrity. Given the central role of the BBB in neurodegeneration, maintaining its integrity represents a promising therapeutic approach to slow or prevent the progression of neurodegenerative diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Science and Biotechnology, Kyungpook National University, Daegu 41566, Republic of Korea.
- BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea.
- Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea.
- Brain Science and Engineering Institute, Kyungpook National University, Daegu 41404, Republic of Korea.
ORCID-Profile: Sang Ryong Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, S., Jung, U. J., & Kim, S. R. (2025). The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications. Journal of Clinical Medicine, 14(2), 386. https://doi.org/10.3390/jcm14020386
Vancouver
Kim S, Jung UJ, Kim SR. The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications. Journal of Clinical Medicine. 2025;14(2):386. doi:10.3390/jcm14020386
BibTeX
@article{Kim2025,
author = {Kim, Sehwan and Jung, Un Ju and Kim, Sang Ryong},
title = {The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {2},
pages = {386},
doi = {10.3390/jcm14020386}
}
EUVIMED